News Conference News ISC 2019 Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke Todd Neale February 12, 2019
News Conference News ISC 2019 Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade Todd Neale February 11, 2019
News Conference News ISC 2019 Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients Todd Neale February 07, 2019
News Conference News STS 2019 Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015 Yael L. Maxwell February 06, 2019
News Conference News STS 2019 No ‘July Effect’ Observed in Cardiac Surgery Yael L. Maxwell February 05, 2019
News Conference News STS 2019 TAVR More Prevalent in Highly Competitive Hospital Markets Yael L. Maxwell February 04, 2019
News Conference News STS 2019 Past SAVR Outcomes Matter More Than Volume in Determining Future Performance Yael L. Maxwell January 31, 2019
News Conference News STS 2019 Blood Conservation Strategy Reduces Need for Transfusion Following Cardiac Surgery Yael L. Maxwell January 29, 2019
News Conference News ISET 2019 PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research Caitlin E. Cox January 28, 2019
News Conference News WCC 2018 Is It Time to Loosen Restrictions on Saturated Fats and Salt? Todd Neale December 14, 2018
News Conference News WCC 2018 Rising CVD Threatens Middle East and North Africa Todd Neale December 13, 2018
News Conference News WCC 2018 Apps? Wearables? Probing Mobile Tech’s Potential to Boost Cardiac Rehab Todd Neale December 07, 2018
News Conference News AHA 2018 Complications Following TAVR Are Going Down, US Data Show Yael L. Maxwell November 20, 2018
News Conference News AHA 2018 Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News AHA 2018 AHA Puts Focus on the Impact of Violence on Cardiovascular Health Todd Neale November 14, 2018
News Conference News AHA 2018 Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs Yael L. Maxwell November 12, 2018
News Conference News AHA 2018 Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF Todd Neale November 11, 2018
News Conference News AHA 2018 Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients Caitlin E. Cox November 11, 2018